AU2018900204A0 - Enhanced viral delivery formulations - Google Patents

Enhanced viral delivery formulations

Info

Publication number
AU2018900204A0
AU2018900204A0 AU2018900204A AU2018900204A AU2018900204A0 AU 2018900204 A0 AU2018900204 A0 AU 2018900204A0 AU 2018900204 A AU2018900204 A AU 2018900204A AU 2018900204 A AU2018900204 A AU 2018900204A AU 2018900204 A0 AU2018900204 A0 AU 2018900204A0
Authority
AU
Australia
Prior art keywords
viral delivery
delivery formulations
enhanced viral
enhanced
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018900204A
Inventor
Clement Leong
Geoffrey Alan Pietersz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ascend Biopharmaceuticals Pty Ltd
Original Assignee
Ascend Biopharmaceuticals Pty Ltd
Filing date
Publication date
Application filed by Ascend Biopharmaceuticals Pty Ltd filed Critical Ascend Biopharmaceuticals Pty Ltd
Publication of AU2018900204A0 publication Critical patent/AU2018900204A0/en
Priority to EP19743365.9A priority Critical patent/EP3743112A4/en
Priority to CA3088700A priority patent/CA3088700A1/en
Priority to CN201980015399.1A priority patent/CN111770763A/en
Priority to PCT/AU2019/050037 priority patent/WO2019144180A1/en
Priority to AU2019210698A priority patent/AU2019210698B2/en
Priority to US16/936,025 priority patent/US20210038660A1/en
Abandoned legal-status Critical Current

Links

AU2018900204A 2018-01-23 2018-01-23 Enhanced viral delivery formulations Abandoned AU2018900204A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP19743365.9A EP3743112A4 (en) 2018-01-23 2019-01-22 Enhanced viral delivery formulation
CA3088700A CA3088700A1 (en) 2018-01-23 2019-01-22 Enhanced viral delivery formulation
CN201980015399.1A CN111770763A (en) 2018-01-23 2019-01-22 Enhanced viral delivery formulations
PCT/AU2019/050037 WO2019144180A1 (en) 2018-01-23 2019-01-22 Enhanced viral delivery formulation
AU2019210698A AU2019210698B2 (en) 2018-01-23 2019-01-22 Enhanced viral delivery formulation
US16/936,025 US20210038660A1 (en) 2018-01-23 2020-07-22 Enhanced viral delivery formulation

Publications (1)

Publication Number Publication Date
AU2018900204A0 true AU2018900204A0 (en) 2018-02-01

Family

ID=

Similar Documents

Publication Publication Date Title
EP3778036A4 (en) Inhaler
EP3638215A4 (en) Rna formulations
EP3582755A4 (en) Formulations
EP4045480A4 (en) Pharmaceutical formulations
EP3890732A4 (en) Injectable formulations
EP3826515A4 (en) Directed delivery system
EP4125815A4 (en) Therapeutic compositions
ZA202006570B (en) Pharmaceutical formulations
IL285674A (en) Pharmaceutical formulations
EP3743084A4 (en) Recombinant viral vaccines
EP3682016A4 (en) Formulations for compound delivery
EP3773730A4 (en) Drug delivery formulations
AU2018303130A1 (en) Single-dose powder-medication inhaler
EP3743112A4 (en) Enhanced viral delivery formulation
EP4007590A4 (en) Formulations including dihydrohonokiol
EP3886820B8 (en) Capsule formulations
EP3866847A4 (en) Virus vaccine
EP3773728A4 (en) Anti-infective formulations
EP3727418A4 (en) Surfactant formulations for inhalation
IL291283A (en) Drug delivery formulations
IL290356A (en) Larazotide formulations
IL284691A (en) Formulations
EP4037741A4 (en) Inhaler
EP3746080A4 (en) Pharmaceutical formulations
EP3775292A4 (en) Virus bioresistors